ST未名: 浙江天册（深圳）律师事务所关于未名医药2025年第一次临时股东会的法律意见书

Core Viewpoint - The legal opinion letter confirms the legality and validity of the procedures, qualifications of attendees, and voting results of the 2025 first extraordinary general meeting of Shandong Weiming Bio-Pharmaceutical Co., Ltd. [1][11] Group 1: Meeting Procedures - The meeting was proposed and convened by the board of directors, with the notice published on July 31, 2025, in designated media and on the Shenzhen Stock Exchange website [2][3] - The meeting combined on-site voting and online voting, held on August 15, 2025, at a specified location in Zibo City, Shandong Province [2][3] Group 2: Attendee Qualifications - Attendees included all registered shareholders of the Shenzhen branch, with the option to appoint proxies [5] - A total of 323 participants attended the meeting, representing 143,261,055 shares, which is 21.7149% of the total voting shares [5] Group 3: Voting Procedures and Results - The voting process adhered to legal and regulatory requirements, with results announced immediately after voting [6][9] - The voting results showed that the proposals received overwhelming support, with significant majorities in favor, including 97.8610% for one proposal and 97.4201% for another [6][8][9]